These findings are supported by Hisamatsu et al. who report that GATA-3 is connected to a less aggressive, HR-positive, HER2-negative phenotype, and therefore with a favorable survival outcome in breast cancer patients30. The gene discussed is ERBB2; the disease is breast carcinoma.